We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
Turnover
9.67%
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+6.43%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$39B
AUM Growth
+$1.59B
(+4.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-1.25%
Top 10 Holdings %
Top 10 Hldgs %
17.8%
Holding
1,046
New
155
Increased
339
Reduced
308
Closed
56
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$309M |
| 2 |
STJ
St Jude Medical
STJ
|
+$72.1M |
| 3 |
General Motors
GM
|
+$46.1M |
| 4 |
Trinity Industries
TRN
|
+$38.8M |
| 5 |
Saic
SAIC
|
+$35.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$84.8M |
| 2 |
SMITHFIELD FOODS,INC
SFD
|
+$80.7M |
| 3 |
Leidos
LDOS
|
+$47.8M |
| 4 |
Parker-Hannifin
PH
|
+$46.4M |
| 5 |
Halliburton
HAL
|
+$46.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.62% |
| 2 | Technology | 14.06% |
| 3 | Healthcare | 13.33% |
| 4 | Energy | 12.59% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
DELISTED
CHUBB CORPORATION
CB
| $193M | 0.49% |
2,157,446
-177,520
| -8% | -$15.4M |
2013 Q2
1 quarter
|
|
77
Helmerich & Payne
HP
$3.75B
| $186M | 0.48% |
2,700,500
+254,800
| +10% | +$16.8M |
2013 Q2
1 quarter
|
|
78
Fifth Third Bancorp
FITB
$45.8B
| $183M | 0.47% |
10,170,003
+660,400
| +7% | +$12.4M |
2013 Q2
1 quarter
|
|
79
Assurant
AIZ
$14B
| $181M | 0.46% |
3,340,586
+23,200
| +0.7% | +$1.25M |
2013 Q2
1 quarter
|
|
80
Hartford Financial Services
HIG
$36.5B
| $175M | 0.45% |
5,631,132
+63,500
| +1% | +$1.98M |
2013 Q2
1 quarter
|
|
81
DELISTED
PARTNERRE LTD
PRE
| $174M | 0.45% |
1,900,214
+67,000
| +4% | +$6M |
2013 Q2
1 quarter
|
|
82
MetLife
MET
$64.3B
| $173M | 0.44% |
4,137,947
+25,207
| +0.6% | +$1.09M |
2013 Q2
1 quarter
|
|
83
Eastman Chemical
EMN
$7.13B
| $166M | 0.42% |
2,127,198
-105,250
| -5% | -$8.11M |
2013 Q2
1 quarter
|
|
84
APA Corp
APA
$17.1B
| $163M | 0.42% |
1,919,411
-58,720
| -3% | -$4.88M |
2013 Q2
1 quarter
|
|
85
Medtronic
MDT
$121B
| $159M | 0.41% |
2,983,628
-211,430
| -7% | -$11.4M |
2013 Q2
1 quarter
|
|
86
KeyCorp
KEY
$21.3B
| $157M | 0.4% |
13,754,830
-390,800
| -3% | -$4.67M |
2013 Q2
1 quarter
|
|
87
GameStop
GME
$13.6B
| $156M | 0.4% |
12,592,800
-2,808,076
| -18% | -$33.6M |
2013 Q2
1 quarter
|
|
88
Entergy
ETR
$50.2B
| $156M | 0.4% |
4,923,880
+97,300
| +2% | +$3.23M |
2013 Q2
1 quarter
|
|
89
Cigna
CI
$79.7B
| $151M | 0.39% |
1,970,241
-61,800
| -3% | -$4.83M |
2013 Q2
1 quarter
|
|
90
CF Industries
CF
$18.3B
| $151M | 0.39% |
3,586,100
-58,700
| -2% | -$2.25M |
2013 Q2
1 quarter
|
|
91
Aflac
AFL
$59.9B
| $149M | 0.38% |
4,817,380
-226,420
| -4% | -$6.82M |
2013 Q2
1 quarter
|
|
|
VR
92
DELISTED
Validus Hold Ltd
VR
| $141M | 0.36% |
3,821,270
+169,935
| +5% | +$6.01M |
2013 Q2
1 quarter
|
|
93
Timken Company
TKR
$7.81B
| $136M | 0.35% |
3,145,257
-392,112
| -11% | -$16.8M |
2013 Q2
1 quarter
|
|
94
Baxter International
BAX
$13.1B
| $136M | 0.35% |
3,800,671
+2,854
| +0.1% | +$111K |
2013 Q2
1 quarter
|
|
95
Unum
UNM
$14.6B
| $134M | 0.34% |
4,413,250
+34,000
| +0.8% | +$1.04M |
2013 Q2
1 quarter
|
|
|
DNY
96
DELISTED
DONNELLEY R R & SONS CO
DNY
| $131M | 0.34% |
8,302,807
+132,944
| +2% | +$2.1M |
2013 Q2
1 quarter
|
|
|
ENDP
97
DELISTED
Endo International plc
ENDP
| $126M | 0.32% |
2,773,409
-794,893
| -22% | -$32M |
2013 Q2
1 quarter
|
|
98
DELISTED
Big Lots, Inc.
BIG
| $122M | 0.31% |
3,289,758
+37,200
| +1% | +$1.32M |
2013 Q2
1 quarter
|
|
99
Johnson & Johnson
JNJ
$615B
| $121M | 0.31% |
1,393,370
+24,970
| +2% | +$2.24M |
2013 Q2
1 quarter
|
|
|
LXK
100
DELISTED
Lexmark Intl Inc
LXK
| $119M | 0.31% |
3,617,368
-55,100
| -2% | -$1.95M |
2013 Q2
1 quarter
|
|
Similar funds
LSV Asset Management's Q3 2013 Portfolio in Review
As of Q3 2013, LSV Asset Management held 1,046 positions worth $39B, up 4.2% from $37.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
LSV Asset Management's Q3 2013 filing shows 155 new, 339 increased, 308 reduced and 56 closed positions. Its largest new stake was Saic: 1,048,636 shares worth $35.4M. The largest sale was Amgen, an estimated $84.8M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- LSV Asset Management's largest Q3 2013 buy was Saic: 1,048,636 shares worth $35.4M.
- LSV Asset Management added most to Oracle in Q3 2013, an estimated $309M increase.
- LSV Asset Management's biggest Q3 2013 reduction was Amgen, cutting an estimated $84.8M.
- LSV Asset Management fully exited SMITHFIELD FOODS,INC in Q3 2013, selling an estimated $80.7M.
- LSV Asset Management's ten largest holdings make up 18% of its $39B portfolio in Q3 2013.
- LSV Asset Management opened 155 new positions and closed 56 in Q3 2013.
- LSV Asset Management's portfolio value rose 4.2% quarter-over-quarter to $39B.
Based on LSV Asset Management's 13F filing for Q3 2013, filed 8 Nov 2013.